Conjugated linoleic
acid (CLA) holds significant application prospects
due to its anticancer, anti-atherosclerosis, lipid-lowering, weight-loss,
and growth-promoting functions. The key to its efficient production
lies in optimizing the biocatalytic performance of linoleic acid isomerase
(LAI). Here, we constructed a Propionibacterium acnes mutant library and screened positive mutants with high linoleate
isomerase activity. The proteomics and metabolomics were used to explore
the mechanism in the regulation of linoleic acid isomerase activity.
High-throughput proteomics revealed 104 differentially expressed proteins
unique to positive mutant strains of linoleic acid isomerase of which
57 were upregulated and 47 were downregulated. These differentially
expressed proteins were primarily involved in galactose metabolism,
the phosphotransferase system, starch metabolism, and sucrose metabolism.
Differential metabolic pathways were mainly enriched in amino acid
biosynthesis, including glutamate metabolism, the Aminoacyl-tRNA biosynthesis
pathway, and the ABC transporter pathway. The upregulated metabolites
include dl-valine and Acetyl coA, while the downregulated
metabolites include Glutamic acid and Phosphoenolpyruvate. Overall,
the activity of linoleic acid isomerase in the mutant strain was increased
by the regulation of key proteins involved in galactose metabolism,
sucrose metabolism, and the phosphotransferase system. This study
provides a theoretical basis for the development of high-yield CLA
food.